NIIMBL Is Now Accepting Applications for the 2024 NIIMBL eXperience Cohort
Newark, Del., October 17, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded approximately $500k in funding to launch the 2024 NIIMBL eXperience program in five locations across the United States. The application period is now open for the following locations: Albany College of Pharmacy and Health Sciences (ACPHS)- New York, Biomanufacturing Training Center at North Carolina State University, Thomas Jefferson University- Pennsylvania, Santa Clara University- California, and the…
NIIMBL awards $370K for 5 eXperience programs in 2024
NIIMBL is pleased to announce it has awarded $370K to launch five NIIMBL eXperience programs next summer. These host locations represent distinct regions across the country. Each location will host a week-long program, designed to introduce Black, Latinx, and Indigenous college students to career possibilities in the biopharmaceutical industry. The 2024 NIIMBL eXperience host locations are…
NIIMBL Announces RFI for Next-Generation Sequencing Method Development Study
NEWARK, Del., August 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for Information (RFI) related to a planned method development study, focused on the development and optimization of Next-Generation Sequencing (NGS) methods for extended characterization of Adeno-Associated Virus (AAV) gene therapy…
NIIMBL Announces New Funding Opportunities
NEWARK, Del., June 8, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $4M in funding through Project Call (PC) 7.1 and an additional $500k in funding for prospective regional leads for the 2024 NIIMBL eXperience Program. The PC7.1 Request for Proposals (RFP) and the 2024 NIIMBL eXperience Requests for Applications (RFA)…
NIIMBL Addresses Talent Pipeline Through Industry and Comm College Collaboration
NEWARK, Del., March 28, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) issues Part II of a whitepaper series titled Innovation of the Biopharmaceutical Manufacturing Talent Pipeline, a series focused on highlighting non-traditional and novel solutions for the talent pipeline gap in the biopharmaceutical industry. The newest whitepaper focuses on successes and challenges faced by community college biotechnology degree programs and makes the case for stronger engagement between…
NIIMBL Announces $1.7M for 3 New Vaccine Manufacturing Projects
NEWARK, Del., February 28, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project activities through the Institute’s Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro potency assays for vaccines being produced by mRNA and/or viral vector…
NIIMBL Announces First Faculty Fellows Program Recipient: Dr. Sarah W. Harcum
Newark, Del., December 20, 2022 — Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces the first recipient of the new Faculty Fellows Program, Dr. Sarah W. Harcum of Clemson University. The NIIMBL Faculty Fellows Program is a pilot program that provides financial support for faculty and instructional staff at universities and community colleges to pursue a sabbatical with NIIMBL industry member organizations or…
NIIMBL Awards over $200k to Expand eXperience Program
Newark, Del., November 15, 2022 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded over $200k in funding to launch the 2023 NIIMBL eXperience program in three distinct locations across the United States. Funding recipients include Albany College (ACPHS) in New York, BioKansas in the Kansas/Missouri Region, and Raritan Valley Community College in…
NIIMBL and BioPhorum Announce Buffer Skid Data and Design for Open Access
NEWARK, Del., October 18, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in collaboration with BioPhorum is pleased to announce that the data and design specification for the NIIMBL BioPhorum Buffer Stock Blending System are now publicly available for open-source use. This new current good manufacturing practices (cGMP) buffer technology is designed, built, and tested to deliver buffer on-demand on a commercial at significant cost savings in labor and cost per liter compared to traditional…
New NIIMBL Whitepaper Addresses Innovation for Today’s Biopharma Talent Pipeline
NEWARK, Del., October 18, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) issues Innovation of the Biopharmaceutical Manufacturing Talent Pipeline, a whitepaper addressing the innovation needs and concerns fueling the employment gap in the biopharmaceutical manufacturing industry. The whitepaper proposes solutions that will directly assist in addressing our nations urgent need for…
NIIMBL Releases First Industry-wide Biomanufacturing Readiness Level Framework
NEWARK, Del., September 29, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces a Biomanufacturing Readiness Levels (BRLs) framework to lay the groundwork for a universal assessment of technology maturity and readiness level for commercial biomanufacturing technology…
$3M from NIST for Equipment to Support Advancements in Biopharma Manufacturing
NEWARK, Del., September 13, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) along with the University of Delaware are pleased to announce $3M in Congressionally-directed funding from the National Institute of Standards and Technology (NIST) for new equipment which will support the advancement of biopharmaceutical manufacturing processes and provide expanded opportunities for workforce development.